Nokia enters into exclusive negotiations for the sale of its Digital Health business
May 02, 2018 09:00 am UTC| Business
Press Release Planned sale of Digital Health to Withings co-founder Éric Carreel would be part of Nokia's shift to become a business-to-business and licensing companyDeal expected to close in late Q2 2018 May 2,...
CN to purchase 350 lumber cars to meet growing demand in forest products business
May 02, 2018 09:00 am UTC| Business
HAMILTON, Ontario, May 02, 2018 -- CN (TSX:CNR) (NYSE:CNI) today announced it will buy 350 centrebeam cars to serve growing demand from lumber producing customers across its North American network. “We are investing...
YPO Innovation Week Unites Global Innovators for Four Signature Events in the United States
May 02, 2018 09:00 am UTC| Business
DALLAS, May 02, 2018 -- As a part of its third annual YPO Innovation Week, YPO will host four signature events in the United States, focusing on the latest innovations and transformations in technology across a variety...
Amarin Reports First Quarter 2018 Financial Results and Provides Update on Operations
May 02, 2018 09:00 am UTC| Business
REDUCE-IT Study On-Track for Reporting Top-Line Results by the End of Q3 2018 Management to Host Conference Call at 7:30 a.m. ET Today BEDMINSTER, N.J. and DUBLIN, Ireland, May 02, 2018 -- Amarin Corporation...
May 02, 2018 09:00 am UTC| Business
BERKELEY, Calif., May 02, 2018 -- AI startup Bonsai today announced, together with Siemens, a technological highlight in deploying AI on a real-world machine in a test environment. Using Bonsai’s AI Platform, Siemens...
May 02, 2018 09:00 am UTC| Business
VANCOUVER, British Columbia, May 02, 2018 -- Fortuna Silver Mines Inc. (NYSE:FSM) (TSX:FVI) announces that it will release its financial statements and MDA for the first quarter after the market closes on Wednesday, May...
AC Immune Reports First Quarter 2018 Financial Results and Corporate Update
May 02, 2018 08:00 am UTC| Business
Announced first-in-human study for an alpha-synuclein PET tracer for Parkinson's disease Selected Tau small molecules (Tau Morphomers) have entered into IND/CTA* enabling studies; Phase 1 to commence by the end of 2018 ...